Search Results - "ODA, Asuka" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma

TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma

by Teramachi, Jumpei, Tenshin, Hirofumi, Hiasa, Masahiro, Oda, Asuka, Bat-Erdene, Ariunzaya, Harada, Takeshi, Nakamura, Shingen, Ashtar, Mohannad, Shimizu, So, Iwasa, Masami, Sogabe, Kimiko, Oura, Masahiro, Fujii, Shiro, Kagawa, Kumiko, Miki, Hirokazu, Endo, Itsuro, Haneji, Tatsuji, Matsumoto, Toshio, Abe, Masahiro
Published in Haematologica (Roma) (01.05.2021)

Get full text

Journal Article

Tgf-Beta inhibition restores terminal osteoblast differentiation to suppress myeloma growth

Tgf-Beta inhibition restores terminal osteoblast differentiation to suppress myeloma growth

by Takeuchi, Kyoko, Abe, Masahiro, Hiasa, Masahiro, Oda, Asuka, Amou, Hiroe, Kido, Shinsuke, Harada, Takeshi, Tanaka, Osamu, Miki, Hirokazu, Nakamura, Shingen, Nakano, Ayako, Kagawa, Kumiko, Yata, Kenichiro, Ozaki, Shuji, Matsumoto, Toshio
Published in PloS one (25.03.2010)

Get full text

Journal Article

Mechanical unloading aggravates bone destruction and tumor expansion in myeloma

Mechanical unloading aggravates bone destruction and tumor expansion in myeloma

by Tanimoto, Kotaro, Hiasa, Masahiro, Tenshin, Hirofumi, Teramachi, Jumpei, Oda, Asuka, Harada, Takeshi, Higa, Yoshiki, Sogabe, Kimiko, Oura, Masahiro, Sumitani, Ryohei, Hara, Tomoyo, Endo, Itsuro, Matsumoto, Toshio, Tanaka, Eiji, Abe, Masahiro
Published in Haematologica (Roma) (18.11.2021)

Get full text

Journal Article

Glycolysis inhibition inactivates ABC transporters to restore drug sensitivity in malignant cells

Glycolysis inhibition inactivates ABC transporters to restore drug sensitivity in malignant cells

by Nakano, Ayako, Tsuji, Daisuke, Miki, Hirokazu, Cui, Qu, El Sayed, Salah Mohamed, Ikegame, Akishige, Oda, Asuka, Amou, Hiroe, Nakamura, Shingen, Harada, Takeshi, Fujii, Shiro, Kagawa, Kumiko, Takeuchi, Kyoko, Sakai, Akira, Ozaki, Shuji, Okano, Kazuma, Nakamura, Takahiro, Itoh, Kohji, Matsumoto, Toshio, Abe, Masahiro
Published in PloS one (02.11.2011)

Get full text

Journal Article

Pim‐2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma

Pim‐2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma

by Teramachi, Jumpei, Hiasa, Masahiro, Oda, Asuka, Harada, Takeshi, Nakamura, Shingen, Amachi, Ryota, Tenshin, Hirofumi, Iwasa, Masami, Fujii, Shiro, Kagawa, Kumiko, Miki, Hirokazu, Kurahashi, Kiyoe, Yoshida, Sumiko, Endo, Itsuro, Haneji, Tatsuji, Matsumoto, Toshio, Abe, Masahiro
Published in British journal of haematology (01.02.2018)

Get full text

Journal Article

The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat

The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat

by Ashtar, Mohannad, Tenshin, Hirofumi, Teramachi, Jumpei, Bat-Erdene, Ariunzaya, Hiasa, Masahiro, Oda, Asuka, Tanimoto, Kotaro, Shimizu, So, Higa, Yoshiki, Harada, Takeshi, Oura, Masahiro, Sogabe, Kimiko, Nakamura, Shingen, Fujii, Shiro, Sumitani, Ryohei, Miki, Hirokazu, Udaka, Kengo, Takahashi, Mamiko, Kagawa, Kumiko, Endo, Itsuro, Tanaka, Eiji, Matsumoto, Toshio, Abe, Masahiro
Published in Cancers (09.04.2020)

Get full text

Journal Article

Myeloma Cell-Osteoclast Interaction Enhances Angiogenesis Together with Bone Resorption: A Role for Vascular Endothelial Cell Growth Factor and Osteopontin

Myeloma Cell-Osteoclast Interaction Enhances Angiogenesis Together with Bone Resorption: A Role for Vascular Endothelial Cell Growth Factor and Osteopontin

by TANAKA, Yoichi, ABE, Masahiro, MORIYAMA, Keiji, HASHIMOTO, Toshihiro, OZAKI, Shuji, MATSUMOTO, Toshio, HIASA, Masahiro, ODA, Asuka, AMOU, Hiroe, NAKANO, Ayako, TAKEUCHI, Kyoko, KITAZOE, Kenichi, KIDO, Shinsuke, INOUE, Daisuke
Published in Clinical cancer research (01.02.2007)

Get full text

Journal Article

The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2

The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2

by Higa, Yoshiki, Hiasa, Masahiro, Tenshin, Hirofumi, Nakaue, Emiko, Tanaka, Mariko, Kim, Sooha, Nakagawa, Motosumi, Shimizu, So, Tanimoto, Kotaro, Teramachi, Jumpei, Harada, Takeshi, Oda, Asuka, Oura, Masahiro, Sogabe, Kimiko, Hara, Tomoyo, Sumitani, Ryohei, Maruhashi, Tomoko, Yamagami, Hiroki, Endo, Itsuro, Matsumoto, Toshio, Tanaka, Eiji, Abe, Masahiro
Published in Antioxidants (05.01.2023)

Get full text

Journal Article

TGF‐β‐activated kinase‐1 inhibitor LL‐Z1640‐2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF‐α and RANKL expression

TGF‐β‐activated kinase‐1 inhibitor LL‐Z1640‐2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF‐α and RANKL expression

by Tenshin, Hirofumi, Teramachi, Jumpei, Ashtar, Mohannad, Hiasa, Masahiro, Inoue, Yusuke, Oda, Asuka, Tanimoto, Kotaro, Shimizu, So, Higa, Yoshiki, Harada, Takeshi, Oura, Masahiro, Sogabe, Kimiko, Hara, Tomoyo, Sumitani, Ryohei, Maruhashi, Tomoko, Sebe, Mayu, Tsutsumi, Rie, Sakaue, Hiroshi, Endo, Itsuro, Matsumoto, Toshio, Tanaka, Eiji, Abe, Masahiro
Published in Clinical & translational immunology (2022)

Get full text

Journal Article

Association of Th1 and Th2 cytokines with transient inflammatory reaction during lenalidomide plus dexamethasone therapy in multiple myeloma

Association of Th1 and Th2 cytokines with transient inflammatory reaction during lenalidomide plus dexamethasone therapy in multiple myeloma

by Harada, Takeshi, Ozaki, Shuji, Oda, Asuka, Fujii, Shiro, Nakamura, Shingen, Miki, Hirokazu, Kagawa, Kumiko, Takeuchi, Kyoko, Matsumoto, Toshio, Abe, Masahiro
Published in International journal of hematology (01.06.2013)

Get full text

Journal Article

Therapeutic efficacy of the resorcylic acid lactone LL‐Z1640‐2 for adult T‐cell leukaemia/lymphoma

Therapeutic efficacy of the resorcylic acid lactone LL‐Z1640‐2 for adult T‐cell leukaemia/lymphoma

by Oura, Masahiro, Harada, Takeshi, Oda, Asuka, Teramachi, Jumpei, Nakayama, Atsushi, Sumitani, Ryohei, Inoue, Yusuke, Maeda, Yusaku, Sogabe, Kimiko, Maruhashi, Tomoko, Takahashi, Mamiko, Fujii, Shiro, Nakamura, Shingen, Miki, Hirokazu, Nakamura, Masafumi, Hara, Tomoyo, Yamagami, Hiroki, Kurahashi, Kiyoe, Endo, Itsuro, Hasegawa, Hiroo, Fujiwara, Hiroshi, Abe, Masahiro
Published in EJHaem (01.08.2023)

Get full text

Journal Article

Combination with a defucosylated anti-HM1.24 monoclonal antibody plus lenalidomide induces marked ADCC against myeloma cells and their progenitors

Combination with a defucosylated anti-HM1.24 monoclonal antibody plus lenalidomide induces marked ADCC against myeloma cells and their progenitors

by Harada, Takeshi, Ozaki, Shuji, Oda, Asuka, Tsuji, Daisuke, Ikegame, Akishige, Iwasa, Masami, Udaka, Kengo, Fujii, Shiro, Nakamura, Shingen, Miki, Hirokazu, Kagawa, Kumiko, Kuroda, Yoshiaki, Kawai, Shigeto, Itoh, Kohji, Yamada-Okabe, Hisafumi, Matsumoto, Toshio, Abe, Masahiro
Published in PloS one (26.12.2013)

Get full text

Journal Article

Factors contributing to deep supercooling capability and cold survival in dwarf bamboo (Sasa senanensis) leaf blades

Factors contributing to deep supercooling capability and cold survival in dwarf bamboo (Sasa senanensis) leaf blades

by Ishikawa, Masaya, Oda, Asuka, Fukami, Reiko, Kuriyama, Akira
Published in Frontiers in plant science (13.01.2015)

Get full text

Journal Article

A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration

A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration

by Amachi, Ryota, Hiasa, Masahiro, Teramachi, Jumpei, Harada, Takeshi, Oda, Asuka, Nakamura, Shingen, Hanson, Derek, Watanabe, Keiichiro, Fujii, Shiro, Miki, Hirokazu, Kagawa, Kumiko, Iwasa, Masami, Endo, Itsuro, Kondo, Takeshi, Yoshida, Sumiko, Aihara, Ken-Ichi, Kurahashi, Kiyoe, Kuroda, Yoshiaki, Horikawa, Hideaki, Tanaka, Eiji, Matsumoto, Toshio, Abe, Masahiro
Published in Oncotarget (25.10.2016)

Get full text

Journal Article

TAK1 inhibition effectively suppresses NLRP3 inflammasome-mediated inflammation and osteoclastic bone resorption in rheumatoid arthritis

TAK1 inhibition effectively suppresses NLRP3 inflammasome-mediated inflammation and osteoclastic bone resorption in rheumatoid arthritis

by Tenshin, Hirofumi, Teramachi, Jumpei, Hiasa, Masahiro, Oda, Asuka, Harada, Takeshi, Oura, Masahiro, Sogabe, Kimiko, Ashtar, Mohannad, Tanimoto, Kotaro, Shimizu, So, Higa, Yoshiki, Tanaka, Eiji, Matsumoto, Toshio, Abe, Masahiro
Published in Bone Reports (01.10.2020)

Get full text

Journal Article

Mechanical unloading enhances bone destruction and tumor expansion in multiple myeloma: Critical roles of osteocytic RANKL induction

Mechanical unloading enhances bone destruction and tumor expansion in multiple myeloma: Critical roles of osteocytic RANKL induction

by Tanimoto, Kotaro, Hiasa, Masahiro, Tenshin, Hirofumi, Teramachi, Jumpei, Oda, Asuka, Harada, Takeshi, Ashter, Mohannad, Sogabe, Kimiko, Oura, Masahiro, Endo, Itsuro, Matsumoto, Toshio, Tanaka, Eiji, Abe, Masahiro
Published in Bone Reports (01.10.2020)

Get full text

Journal Article

The anti-SLAMF7 elotuzumab enhances ADCC activity with Th1-like γδT cells towards osteoclasts and myeloma cells

The anti-SLAMF7 elotuzumab enhances ADCC activity with Th1-like γδT cells towards osteoclasts and myeloma cells

by Tenshin, Hirofumi, Harada, Takeshi, Inoue, Yusuke, Teramachi, Jumpei, Hiasa, Masahiro, Oda, Asuka, Tanimoto, Kotaro, Shimizu, So, Higa, Yoshiki, Oura, Masahiro, Sogabe, Kimiko, Hara, Tomoyo, Maruhashi, Tomoko, Endo, Itsuro, Matsumoto, Toshio, Tanaka, Eiji, Abe, Masahiro
Published in Bone Reports (01.04.2021)

Get full text

Journal Article

Inhibition of TACE activity enhances the susceptibility of myeloma cells to TRAIL

Inhibition of TACE activity enhances the susceptibility of myeloma cells to TRAIL

by Kagawa, Kumiko, Nakano, Ayako, Miki, Hirokazu, Oda, Asuka, Amou, Hiroe, Takeuchi, Kyoko, Nakamura, Shingen, Harada, Takeshi, Fujii, Shiro, Yata, Kenichiro, Ozaki, Shuji, Matsumoto, Toshio, Abe, Masahiro
Published in PloS one (28.02.2012)

Get full text

Journal Article

Reveromycin A, a novel acid-seeking agent, ameliorates bone destruction and tumor growth in multiple myeloma

Reveromycin A, a novel acid-seeking agent, ameliorates bone destruction and tumor growth in multiple myeloma

by Watanabe, Keiichiro, Bat-Erdene, Ariunzaya, Tenshin, Hirofumi, Cui, Qu, Teramachi, Jumpei, Hiasa, Masahiro, Oda, Asuka, Harada, Takeshi, Miki, Hirokazu, Sogabe, Kimiko, Oura, Masahiro, Sumitani, Ryohei, Mitsui, Yukari, Endo, Itsuro, Tanaka, Eiji, Kawatani, Makoto, Osada, Hiroyuki, Matsumoto, Toshio, Abe, Masahiro
Published in Haematologica (Roma) (01.04.2021)

Get full text

Journal Article

Activating transcription factor 4, an ER stress mediator, is required for, but excessive ER stress suppresses osteoblastogenesis by bortezomib

Activating transcription factor 4, an ER stress mediator, is required for, but excessive ER stress suppresses osteoblastogenesis by bortezomib

by Nakamura, Shingen, Miki, Hirokazu, Kido, Shinsuke, Nakano, Ayako, Hiasa, Masahiro, Oda, Asuka, Amou, Hiroe, Watanabe, Keiichiro, Harada, Takeshi, Fujii, Shiro, Takeuchi, Kyoko, Kagawa, Kumiko, Ozaki, Shuji, Matsumoto, Toshio, Abe, Masahiro
Published in International journal of hematology (01.07.2013)

Get full text

Journal Article